Bicara Therapeutics Inc. (BCAX) stock
BCAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.60−0.15 (-1.54%)
Close on Nov 17, 2026Market cap $635.26MP/E –Yield –
Bicara Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Bicara Therapeutics's total assets was $460.64M at Sep 30, 2026. For fiscal 2025 it was $430.99M, down 15.5% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $430.99M | -15.5% |
| FY2024 | Dec 31, 2024 | $510.00M | +118.0% |
| FY2023 | Dec 31, 2023 | $233.98M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $460.64M | +8.5% |
| Q2 FY2026 | Jun 30, 2026 | $512.24M | +12.9% |
| Q1 FY2026 | Mar 31, 2026 | $553.60M | +15.8% |
| Q4 FY2025 | Dec 31, 2025 | $430.99M | -15.5% |
| Q3 FY2025 | Sep 30, 2025 | $424.69M | -19.0% |
| Q2 FY2025 | Jun 30, 2025 | $453.59M | +93.9% |
| Q1 FY2025 | Mar 31, 2025 | $478.08M | – |
| Q4 FY2024 | Dec 31, 2024 | $510.00M | – |
| Q3 FY2024 | Sep 30, 2024 | $524.17M | – |
| Q4 FY2023 | Dec 31, 2023 | $233.98M | – |
See a number that looks wrong?